首页 > 最新文献

Diagnostic Cytopathology最新文献

英文 中文
Cytopathology in the era of social media 社交媒体时代的细胞病理学。
IF 1 4区 医学 Q4 MEDICAL LABORATORY TECHNOLOGY Pub Date : 2024-05-07 DOI: 10.1002/dc.25339
Swikrity Baskota MD, Nada Shaker MD, MS, Ronald Balassanian MD, Poonam Vohra MD

In today's medical landscape, social media (SoMe) platforms have expanded their reach beyond mere communication and entertainment, making a significant impact in the pathology field, including cytopathology. In recent years, SoMe platforms have become increasingly adopted by cytopathologists, facilitating continued education, professional networking, enhancing patient engagement, and entertainment. This adoption has influenced the professional growth of cytopathologists, and at its best, has led to the establishment of a robust professional online presence and ultimately contributed to leadership positions, fellowship opportunities, and academic promotions. Moreover, the integration of SoMe into the academic field has shown a profound impact on the visibility of academic journals and has provided a platform for lower-impact factor journals to expand their reach, ultimately increasing article citation rates and positively contributing to journal impact factor growth. SoMe platforms created a modern avenue for conference networking that has revolutionized knowledge dissemination and enhanced real-time engagement. The advantages of SoMe have extended to a global scale, positively enhancing professional expertise sharing, facilitating effective communication and teleconsultation worldwide, and reaching developing countries. Drawing insights from the recent medical literature and the practical insight from the experts' personal experience, this article provides a comprehensive review of how SoMe and cytopathology intersect to create new opportunities, facilitating informed discussions, global collaboration, and advancements in the field of cytopathology. This article also delves into the challenges surrounding SoMe platform navigation and addresses ethical and regulatory concerns, providing guidelines on what to post and what not to post on SoMe platforms.

在当今的医疗领域,社交媒体 (SoMe) 平台的影响力已经超越了单纯的交流和娱乐,对包括细胞病理学在内的病理学领域产生了重大影响。近年来,SoMe 平台被越来越多的细胞病理学家所采用,促进了继续教育、专业网络、提高患者参与度和娱乐性。这种应用影响了细胞病理学家的专业成长,在最好的情况下,建立了强大的专业在线形象,并最终促成了领导职位、奖学金机会和学术晋升。此外,SoMe 与学术领域的融合对学术期刊的知名度产生了深远影响,并为影响因子较低的期刊提供了扩大影响力的平台,最终提高了文章的引用率,积极促进了期刊影响因子的增长。SoMe 平台创造了一个现代化的会议网络渠道,彻底改变了知识传播方式,增强了实时参与性。SoMe 的优势已扩展到全球范围,积极加强了专业知识的共享,促进了全球范围内的有效沟通和远程会诊,并深入到发展中国家。本文从最新医学文献和专家个人经验中汲取真知灼见,全面回顾了 SoMe 与细胞病理学如何相互交织以创造新机遇,促进细胞病理学领域的知情讨论、全球合作和进步。本文还深入探讨了围绕SoMe平台导航的挑战,解决了伦理和监管方面的问题,为在SoMe平台上发布什么和不发布什么提供了指南。
{"title":"Cytopathology in the era of social media","authors":"Swikrity Baskota MD,&nbsp;Nada Shaker MD, MS,&nbsp;Ronald Balassanian MD,&nbsp;Poonam Vohra MD","doi":"10.1002/dc.25339","DOIUrl":"10.1002/dc.25339","url":null,"abstract":"<p>In today's medical landscape, social media (SoMe) platforms have expanded their reach beyond mere communication and entertainment, making a significant impact in the pathology field, including cytopathology. In recent years, SoMe platforms have become increasingly adopted by cytopathologists, facilitating continued education, professional networking, enhancing patient engagement, and entertainment. This adoption has influenced the professional growth of cytopathologists, and at its best, has led to the establishment of a robust professional online presence and ultimately contributed to leadership positions, fellowship opportunities, and academic promotions. Moreover, the integration of SoMe into the academic field has shown a profound impact on the visibility of academic journals and has provided a platform for lower-impact factor journals to expand their reach, ultimately increasing article citation rates and positively contributing to journal impact factor growth. SoMe platforms created a modern avenue for conference networking that has revolutionized knowledge dissemination and enhanced real-time engagement. The advantages of SoMe have extended to a global scale, positively enhancing professional expertise sharing, facilitating effective communication and teleconsultation worldwide, and reaching developing countries. Drawing insights from the recent medical literature and the practical insight from the experts' personal experience, this article provides a comprehensive review of how SoMe and cytopathology intersect to create new opportunities, facilitating informed discussions, global collaboration, and advancements in the field of cytopathology. This article also delves into the challenges surrounding SoMe platform navigation and addresses ethical and regulatory concerns, providing guidelines on what to post and what not to post on SoMe platforms.</p>","PeriodicalId":11349,"journal":{"name":"Diagnostic Cytopathology","volume":null,"pages":null},"PeriodicalIF":1.0,"publicationDate":"2024-05-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140854096","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cytopathology: From its humble beginnings to the birth of the cytopathology fellowship 细胞病理学:从默默无闻到细胞病理学奖学金的诞生
IF 1 4区 医学 Q4 MEDICAL LABORATORY TECHNOLOGY Pub Date : 2024-05-04 DOI: 10.1002/dc.25329
Simon Sung MD, Rema Chaari MD, Rao

Cytopathology or cytology as a field has grown remarkably in the 20th and 21st centuries with recent advances shaping the way we train our future colleagues and how we currently practice. This article explores the history of cytopathology tracing back as early as the 18th century with focus on the birth of the cytopathology fellowship in the United States.

细胞病理学或细胞学作为一个领域,在 20 世纪和 21 世纪得到了长足的发展,其最新进展影响着我们培训未来同行的方式以及我们目前的实践方式。本文探讨了细胞病理学的历史,最早可追溯到 18 世纪,重点介绍了细胞病理学奖学金在美国的诞生。
{"title":"Cytopathology: From its humble beginnings to the birth of the cytopathology fellowship","authors":"Simon Sung MD,&nbsp;Rema Chaari MD,&nbsp;Rao","doi":"10.1002/dc.25329","DOIUrl":"10.1002/dc.25329","url":null,"abstract":"<p>Cytopathology or cytology as a field has grown remarkably in the 20th and 21st centuries with recent advances shaping the way we train our future colleagues and how we currently practice. This article explores the history of cytopathology tracing back as early as the 18th century with focus on the birth of the cytopathology fellowship in the United States.</p>","PeriodicalId":11349,"journal":{"name":"Diagnostic Cytopathology","volume":null,"pages":null},"PeriodicalIF":1.0,"publicationDate":"2024-05-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140834657","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Importance of mediastinal granulomatous/sarcoid-like lymphadenopathy in extrathoracic malignancies 纵隔肉芽肿/类肉芽肿淋巴结病在胸腔外恶性肿瘤中的重要性
IF 1 4区 医学 Q4 MEDICAL LABORATORY TECHNOLOGY Pub Date : 2024-05-01 DOI: 10.1002/dc.25337
Serhat Erol MD, Aslıhan Gurun Kaya MD, Fatma Arslan MD, Mirac Oz MD, Deniz Doğan Mulazimoglu MD, Ozlem Isık MD, Aydin Ciledag MD, Koray Ceyhan MD, Demet Karnak MD, Elif Sen MD, Gokhan Celik MD, Akin Kaya MD, Ismail Savas MD

Background

In patients with extrathoracic malignancies (ETM), granulomatous lymph adenopathy called sarcoid-like reactions (SLR) can be seen in the regional or draining lymph nodes. We hypothesized that SLR may be a sign of imminent metastasis and investigated the clinical course and rate of recurrence in patients with ETM and granulomatous mediastinal lymphadenopathy (MLN).

Methods

In this retrospective observational study, we reviewed the medical files of patients with known ETM and who underwent EBUS-TBNA for initial staging or detection of recurrence from 2011 to 2023. Patients with granulomatous MLN were included.

Results

Forty-one patients (29 female) enrolled in the study. Breast and colorectal carcinomas were the most common malignancies. A total of 81 lymph nodes were sampled. The final diagnosis of patients was five sarcoidosis, one tuberculosis, one second primary, one drug reaction, and 33 SLR. Among patients with SLR, in one patient lymph nodes progressed during the follow-up and were accepted as false-negative without confirmatory biopsy. The negative predictive value (NPV) of granulomatous MLN for metastasis was 97.05%.

Conclusion

Granulomatous MLN may be due to tuberculosis, drug reaction, sarcoidosis, or SLR in patients with ETM. SLR has a high NPV in patients with ETM. Follow-up imaging rather than confirmatory biopsy is reasonable in these patients.

背景胸外恶性肿瘤(ETM)患者的区域淋巴结或引流淋巴结可出现肉芽肿性淋巴腺病,称为类肉芽肿反应(SLR)。我们假设 SLR 可能是即将发生转移的征兆,并对 ETM 和肉芽肿性纵隔淋巴结病(MLN)患者的临床病程和复发率进行了调查。方法在这项回顾性观察研究中,我们回顾了 2011 年至 2023 年期间已知 ETM 并接受 EBUS-TBNA 进行初步分期或复发检测的患者的医疗档案。结果41名患者(29名女性)参加了研究。乳腺癌和结直肠癌是最常见的恶性肿瘤。共采集了 81 个淋巴结样本。患者的最终诊断为 5 例肉芽肿病、1 例结核病、1 例第二原发性、1 例药物反应和 33 例 SLR。在 SLR 患者中,有一名患者的淋巴结在随访期间出现进展,未经活检确诊即被视为假阴性。肉芽肿性 MLN 转移的阴性预测值(NPV)为 97.05%。在 ETM 患者中,SLR 的 NPV 很高。对这些患者进行随访成像而非确诊活检是合理的。
{"title":"Importance of mediastinal granulomatous/sarcoid-like lymphadenopathy in extrathoracic malignancies","authors":"Serhat Erol MD,&nbsp;Aslıhan Gurun Kaya MD,&nbsp;Fatma Arslan MD,&nbsp;Mirac Oz MD,&nbsp;Deniz Doğan Mulazimoglu MD,&nbsp;Ozlem Isık MD,&nbsp;Aydin Ciledag MD,&nbsp;Koray Ceyhan MD,&nbsp;Demet Karnak MD,&nbsp;Elif Sen MD,&nbsp;Gokhan Celik MD,&nbsp;Akin Kaya MD,&nbsp;Ismail Savas MD","doi":"10.1002/dc.25337","DOIUrl":"10.1002/dc.25337","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>In patients with extrathoracic malignancies (ETM), granulomatous lymph adenopathy called sarcoid-like reactions (SLR) can be seen in the regional or draining lymph nodes. We hypothesized that SLR may be a sign of imminent metastasis and investigated the clinical course and rate of recurrence in patients with ETM and granulomatous mediastinal lymphadenopathy (MLN).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>In this retrospective observational study, we reviewed the medical files of patients with known ETM and who underwent EBUS-TBNA for initial staging or detection of recurrence from 2011 to 2023. Patients with granulomatous MLN were included.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Forty-one patients (29 female) enrolled in the study. Breast and colorectal carcinomas were the most common malignancies. A total of 81 lymph nodes were sampled. The final diagnosis of patients was five sarcoidosis, one tuberculosis, one second primary, one drug reaction, and 33 SLR. Among patients with SLR, in one patient lymph nodes progressed during the follow-up and were accepted as false-negative without confirmatory biopsy. The negative predictive value (NPV) of granulomatous MLN for metastasis was 97.05%.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>Granulomatous MLN may be due to tuberculosis, drug reaction, sarcoidosis, or SLR in patients with ETM. SLR has a high NPV in patients with ETM. Follow-up imaging rather than confirmatory biopsy is reasonable in these patients.</p>\u0000 </section>\u0000 </div>","PeriodicalId":11349,"journal":{"name":"Diagnostic Cytopathology","volume":null,"pages":null},"PeriodicalIF":1.0,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/dc.25337","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140834660","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Renal B-lymphoblastic lymphoma with hematuria as the first symptom diagnosed in urine cytology: A case report and literature review 以血尿为首发症状的肾B淋巴细胞淋巴瘤经尿液细胞学确诊:病例报告和文献综述
IF 1 4区 医学 Q4 MEDICAL LABORATORY TECHNOLOGY Pub Date : 2024-04-29 DOI: 10.1002/dc.25336
Hong Xu MD, PhD, Changwei Yang MM, Yingmei Wang MM, Shirong Ma MM, Jing Zhang MD, PhD

Cytological examination of urine sediment is a helpful diagnostic tool for identifying renal involvement by hematological malignancies. We present the case of a 47-year-old man who was diagnosed with extranodal B-lymphoblastic lymphomas after presenting with gross hematuria as his first symptom. The presence of lymphoma cells in the urine led to a diagnosis confirmed through an immunophenotypic study using cell block sections of urine centrifuge sediment and core needle biopsy histology of the right renal pelvis mass. This case highlights the usefulness of a urine cytological study in diagnosing lymphoma involvement in the genitourinary tract. Furthermore, this paper reviews relevant literature on diagnosing lymphoma involvement from urine sediment.

尿沉渣细胞学检查是鉴别血液恶性肿瘤累及肾脏的有效诊断工具。我们介绍了一例 47 岁男子的病例,他以毛细血尿为首发症状,被诊断为结节外 B 淋巴细胞淋巴瘤。尿液中出现淋巴瘤细胞后,通过对尿液离心沉淀物的细胞块切片和右肾盂肿块的核心针活检组织学进行免疫分型研究,确诊了淋巴瘤。该病例凸显了尿液细胞学研究在诊断淋巴瘤累及泌尿生殖道方面的作用。此外,本文还回顾了通过尿沉渣诊断淋巴瘤受累的相关文献。
{"title":"Renal B-lymphoblastic lymphoma with hematuria as the first symptom diagnosed in urine cytology: A case report and literature review","authors":"Hong Xu MD, PhD,&nbsp;Changwei Yang MM,&nbsp;Yingmei Wang MM,&nbsp;Shirong Ma MM,&nbsp;Jing Zhang MD, PhD","doi":"10.1002/dc.25336","DOIUrl":"10.1002/dc.25336","url":null,"abstract":"<p>Cytological examination of urine sediment is a helpful diagnostic tool for identifying renal involvement by hematological malignancies. We present the case of a 47-year-old man who was diagnosed with extranodal B-lymphoblastic lymphomas after presenting with gross hematuria as his first symptom. The presence of lymphoma cells in the urine led to a diagnosis confirmed through an immunophenotypic study using cell block sections of urine centrifuge sediment and core needle biopsy histology of the right renal pelvis mass. This case highlights the usefulness of a urine cytological study in diagnosing lymphoma involvement in the genitourinary tract. Furthermore, this paper reviews relevant literature on diagnosing lymphoma involvement from urine sediment.</p>","PeriodicalId":11349,"journal":{"name":"Diagnostic Cytopathology","volume":null,"pages":null},"PeriodicalIF":1.0,"publicationDate":"2024-04-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140834589","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A case of fine-needle aspiration of a neck mass with atypical squamous cells and macrophages 一例颈部肿块的细针抽吸术,其中有非典型鳞状细胞和巨噬细胞
IF 1 4区 医学 Q4 MEDICAL LABORATORY TECHNOLOGY Pub Date : 2024-04-26 DOI: 10.1002/dc.25326
Megan L. Zilla MD, PhD, Sigfred Lajara MD

Head and neck lesions often undergo fine-needle aspiration to determine the appropriate management and therapeutic decisions. However, there are numerous diagnostic challenges encountered with these specimens, particularly, if atypical squamous cells are identified. Here, we present a case of an enlarging right neck mass in a 38-year-old female and discuss the diagnostic difficulties and potential pitfalls. Additionally, we review the approach to diagnosis, including differential diagnostic considerations as well as available ancillary testing.

头颈部病变通常需要进行细针穿刺,以确定适当的处理和治疗方案。然而,这些标本在诊断方面会遇到许多挑战,尤其是在发现非典型鳞状细胞时。在此,我们介绍了一例 38 岁女性右颈部肿块增大的病例,并讨论了诊断困难和潜在的陷阱。此外,我们还回顾了诊断方法,包括鉴别诊断的考虑因素以及可用的辅助检查。
{"title":"A case of fine-needle aspiration of a neck mass with atypical squamous cells and macrophages","authors":"Megan L. Zilla MD, PhD,&nbsp;Sigfred Lajara MD","doi":"10.1002/dc.25326","DOIUrl":"10.1002/dc.25326","url":null,"abstract":"<p>Head and neck lesions often undergo fine-needle aspiration to determine the appropriate management and therapeutic decisions. However, there are numerous diagnostic challenges encountered with these specimens, particularly, if atypical squamous cells are identified. Here, we present a case of an enlarging right neck mass in a 38-year-old female and discuss the diagnostic difficulties and potential pitfalls. Additionally, we review the approach to diagnosis, including differential diagnostic considerations as well as available ancillary testing.</p>","PeriodicalId":11349,"journal":{"name":"Diagnostic Cytopathology","volume":null,"pages":null},"PeriodicalIF":1.0,"publicationDate":"2024-04-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/dc.25326","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140811844","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of dual p16/Ki-67 immunostaining on anal cytology specimens 评估肛门细胞学标本上的 p16/Ki-67 双免疫染色。
IF 1 4区 医学 Q4 MEDICAL LABORATORY TECHNOLOGY Pub Date : 2024-04-26 DOI: 10.1002/dc.25332
Marie C. Smithgall MD, William S. Towne MD, Abel A. Gonzalez MD, Adela Cimic MD

Introduction

Dual immunostaining for p16/Ki67 is FDA-approved for use on liquid-based cervical cytology specimens; however, the utility of dual staining in anal cytology especially for ASCUS risk stratification is not well established.

Methods

We investigated dual staining performance on anal cytology specimens and correlated with subsequent cytologic interpretation, high-risk HPV status, and anal biopsy results. Dual staining for p16/Ki-67 was performed on all liquid-based anal cytology specimens from December 2021 to June 2022 (n = 43).

Results

Three patients had high grade squamous intraepithelial lesion (HSIL/AIN2-3) on biopsy; dual staining was positive in all three cases. All HR-HPV negative cases were negative for dual staining. Among the 12 ASCUS samples with subsequent anal biopsy results all also had HR-HPV testing. Due to small sample size of cases with squamous intraepithelial lesion (SIL) diagnosed on biopsy, the sensitivity and positive predictive value was not calculated. However, the specificity and negative predictive value of p16/Ki-67 dual staining for SIL of any grade on biopsy were 1 (95% CI: 0.66–1) and 0.9 (95% CI: 0.65–0.97) respectively, whereas the specificity and negative predictive value of HR-HPV testing for SIL of any grade on biopsy were 0.44 (95% CI: 0.14–0.79) and 0.8 (95% CI: 0.41–0.96) respectively.

Conclusion

Dual p16/Ki-67 staining indicates transforming HPV infection and could help serve as an ancillary test for risk stratification for atypical anal cytology specimens. Among ASCUS samples, dual staining was specific for SIL of any grade with a high negative predictive value and therefore could be useful in clinical practices with limited availability for follow-up care.

引言p16/Ki67的双重免疫染色已获得FDA批准,可用于液基宫颈细胞学标本;然而,双重染色在肛门细胞学尤其是ASCUS风险分层中的实用性尚未得到很好的证实。方法我们研究了肛门细胞学标本的双重染色性能,并将其与随后的细胞学解释、高危HPV状态和肛门活检结果相关联。结果3例患者活检时发现高级别鳞状上皮内病变(HSIL/AIN2-3);所有3例患者的双重染色均为阳性。所有 HR-HPV 阴性病例的双重染色均为阴性。在随后进行肛门活检的 12 例 ASCUS 样本中,所有样本都进行了 HR-HPV 检测。由于活检确诊为鳞状上皮内病变(SIL)的病例样本量较少,因此没有计算灵敏度和阳性预测值。然而,p16/Ki-67 双染色对活检任何级别 SIL 的特异性和阴性预测值分别为 1(95% CI:0.66-1)和 0.9(95% CI:0.65-0.97),而 HR-HPV 检测对活检任何级别 SIL 的特异性和阴性预测值分别为 0.结论p16/Ki-67双重染色提示转化型HPV感染,有助于作为非典型肛门细胞学标本风险分层的辅助检测。在ASCUS样本中,双重染色对任何级别的SIL都有特异性,且具有较高的阴性预测值,因此可用于后续护理有限的临床实践中。
{"title":"Evaluation of dual p16/Ki-67 immunostaining on anal cytology specimens","authors":"Marie C. Smithgall MD,&nbsp;William S. Towne MD,&nbsp;Abel A. Gonzalez MD,&nbsp;Adela Cimic MD","doi":"10.1002/dc.25332","DOIUrl":"10.1002/dc.25332","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Introduction</h3>\u0000 \u0000 <p>Dual immunostaining for p16/Ki67 is FDA-approved for use on liquid-based cervical cytology specimens; however, the utility of dual staining in anal cytology especially for ASCUS risk stratification is not well established.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>We investigated dual staining performance on anal cytology specimens and correlated with subsequent cytologic interpretation, high-risk HPV status, and anal biopsy results. Dual staining for p16/Ki-67 was performed on all liquid-based anal cytology specimens from December 2021 to June 2022 (<i>n</i> = 43).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Three patients had high grade squamous intraepithelial lesion (HSIL/AIN2-3) on biopsy; dual staining was positive in all three cases. All HR-HPV negative cases were negative for dual staining. Among the 12 ASCUS samples with subsequent anal biopsy results all also had HR-HPV testing. Due to small sample size of cases with squamous intraepithelial lesion (SIL) diagnosed on biopsy, the sensitivity and positive predictive value was not calculated. However, the specificity and negative predictive value of p16/Ki-67 dual staining for SIL of any grade on biopsy were 1 (95% CI: 0.66–1) and 0.9 (95% CI: 0.65–0.97) respectively, whereas the specificity and negative predictive value of HR-HPV testing for SIL of any grade on biopsy were 0.44 (95% CI: 0.14–0.79) and 0.8 (95% CI: 0.41–0.96) respectively.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>Dual p16/Ki-67 staining indicates transforming HPV infection and could help serve as an ancillary test for risk stratification for atypical anal cytology specimens. Among ASCUS samples, dual staining was specific for SIL of any grade with a high negative predictive value and therefore could be useful in clinical practices with limited availability for follow-up care.</p>\u0000 </section>\u0000 </div>","PeriodicalId":11349,"journal":{"name":"Diagnostic Cytopathology","volume":null,"pages":null},"PeriodicalIF":1.0,"publicationDate":"2024-04-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140652127","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Parotid squamous cell carcinoma metastases: Application of human papillomavirus-DNA test on liquid-based cytology to recognize oropharyngeal origin of the neoplasm 腮腺鳞状细胞癌转移:在液基细胞学中应用人类乳头状瘤病毒 DNA 检测来识别口咽部肿瘤来源
IF 1 4区 医学 Q4 MEDICAL LABORATORY TECHNOLOGY Pub Date : 2024-04-26 DOI: 10.1002/dc.25334
Marco Montella MD, PhD, Raffaella Ruggiero BD, Giovanni Savarese BD, Giuseppe Colella MD, Andrea Ronchi MD, PhD, Renato Franco, Immacolata Cozzolino MD, PhD

Malignancies of the parotid gland are relatively uncommon and in most cases are primary neoplasms; intraparotid metastases are rare. Oral and oropharyngeal squamous cell carcinoma (O- and OP-SCC) can potentially metastasize to the parotid gland or intraparotid lymph nodes. Fine-needle aspiration cytology (FNAC) serves as the initial diagnostic approach for this purpose. HPV status in FNAC specimens is relevant and can guide the diagnostic workup, indicating a potential oropharyngeal origin of the primary tumor. A small series of occult SCC metastases is presented below, in which HPV-DNA testing of FNAC specimens helped identify primary neoplasms located in the oropharynx. US-guided FNAC of parotid nodules was conducted by an experienced interventional cytopathologist in three cases. Each patient underwent assessment of direct smears, cell blocks, and liquid-based samples for HPV testing. The morphological and immunocytochemical features of SCC were documented, and real-time PCR was employed for the detection and genotyping of HPV. The role of HPV testing on FNAC specimens in pinpointing the primary neoplasms in the oropharynx is highlighted. Consequently, FNAC samples emerge as valuable diagnostic and prognostic tools in this context, providing essential insights for patient management.

腮腺恶性肿瘤相对来说并不常见,大多数情况下都是原发性肿瘤;腮腺内转移非常罕见。口腔鳞状细胞癌和口咽鳞状细胞癌(O-和 OP-SCC)有可能转移到腮腺或腮腺内淋巴结。为此,细针穿刺细胞学检查(FNAC)是初步诊断方法。FNAC 标本中的 HPV 状态具有相关性,可以指导诊断工作,表明原发肿瘤可能来自口咽部。下文介绍了一个隐匿性 SCC 转移的小型系列,其中 FNAC 标本的 HPV DNA 检测有助于确定位于口咽部的原发肿瘤。经验丰富的介入性细胞病理学家在 US 引导下对三例患者的腮腺结节进行了 FNAC 检查。每位患者都接受了直接涂片、细胞块和用于HPV检测的液基样本的评估。对 SCC 的形态学和免疫细胞化学特征进行了记录,并采用实时 PCR 对 HPV 进行检测和基因分型。FNAC 标本的 HPV 检测在确定口咽部原发性肿瘤方面的作用得到了强调。因此,在这种情况下,FNAC 标本成为有价值的诊断和预后工具,为患者管理提供了重要的见解。
{"title":"Parotid squamous cell carcinoma metastases: Application of human papillomavirus-DNA test on liquid-based cytology to recognize oropharyngeal origin of the neoplasm","authors":"Marco Montella MD, PhD,&nbsp;Raffaella Ruggiero BD,&nbsp;Giovanni Savarese BD,&nbsp;Giuseppe Colella MD,&nbsp;Andrea Ronchi MD, PhD,&nbsp;Renato Franco,&nbsp;Immacolata Cozzolino MD, PhD","doi":"10.1002/dc.25334","DOIUrl":"10.1002/dc.25334","url":null,"abstract":"<p>Malignancies of the parotid gland are relatively uncommon and in most cases are primary neoplasms; intraparotid metastases are rare. Oral and oropharyngeal squamous cell carcinoma (O- and OP-SCC) can potentially metastasize to the parotid gland or intraparotid lymph nodes. Fine-needle aspiration cytology (FNAC) serves as the initial diagnostic approach for this purpose. HPV status in FNAC specimens is relevant and can guide the diagnostic workup, indicating a potential oropharyngeal origin of the primary tumor. A small series of occult SCC metastases is presented below, in which HPV-DNA testing of FNAC specimens helped identify primary neoplasms located in the oropharynx. US-guided FNAC of parotid nodules was conducted by an experienced interventional cytopathologist in three cases. Each patient underwent assessment of direct smears, cell blocks, and liquid-based samples for HPV testing. The morphological and immunocytochemical features of SCC were documented, and real-time PCR was employed for the detection and genotyping of HPV. The role of HPV testing on FNAC specimens in pinpointing the primary neoplasms in the oropharynx is highlighted. Consequently, FNAC samples emerge as valuable diagnostic and prognostic tools in this context, providing essential insights for patient management.</p>","PeriodicalId":11349,"journal":{"name":"Diagnostic Cytopathology","volume":null,"pages":null},"PeriodicalIF":1.0,"publicationDate":"2024-04-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140811979","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cytopathology fellowship and practice: Are our trainees and cytopathologists diverse? 细胞病理学研究与实践:我们的受训人员和细胞病理学家是多样化的吗?
IF 1 4区 医学 Q4 MEDICAL LABORATORY TECHNOLOGY Pub Date : 2024-04-25 DOI: 10.1002/dc.25330
Valerie A. Fitzhugh MD

Over the last several years, there has been increased focus on diversity, equity, and inclusion within all areas of pathology and laboratory medicine. Many of the specialty societies within pathology have taken up the mantle of diversity. While there is little research into the diversity of cytopathologists in practice, the Accreditation Council for Graduate Medical Education (ACGME) has been collecting diversity data on pathology and laboratory medicine trainees since 2011. This data are an opportunity to explore how diverse our trainees in cytopathology are, and by extrapolation, allows us to develop some ideas as to how diverse attending level cytopathologists are. The author will also share personal observations from her own training and career regarding diversity in cytopathology.

在过去的几年里,病理学和检验医学的各个领域都越来越重视多样性、公平性和包容性。病理学领域的许多专科学会都开始关注多样性问题。虽然对细胞病理学家在实践中的多样性研究很少,但毕业医学教育认证委员会(ACGME)自 2011 年以来一直在收集病理学和检验医学受训人员的多样性数据。这些数据为我们提供了一个探索细胞病理学受训者多样性的机会,通过推断,我们可以对细胞病理学主治医生的多样性有一些想法。作者还将分享她在自己的培训和职业生涯中对细胞病理学多样性的个人观察。
{"title":"Cytopathology fellowship and practice: Are our trainees and cytopathologists diverse?","authors":"Valerie A. Fitzhugh MD","doi":"10.1002/dc.25330","DOIUrl":"10.1002/dc.25330","url":null,"abstract":"<p>Over the last several years, there has been increased focus on diversity, equity, and inclusion within all areas of pathology and laboratory medicine. Many of the specialty societies within pathology have taken up the mantle of diversity. While there is little research into the diversity of cytopathologists in practice, the Accreditation Council for Graduate Medical Education (ACGME) has been collecting diversity data on pathology and laboratory medicine trainees since 2011. This data are an opportunity to explore how diverse our trainees in cytopathology are, and by extrapolation, allows us to develop some ideas as to how diverse attending level cytopathologists are. The author will also share personal observations from her own training and career regarding diversity in cytopathology.</p>","PeriodicalId":11349,"journal":{"name":"Diagnostic Cytopathology","volume":null,"pages":null},"PeriodicalIF":1.0,"publicationDate":"2024-04-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/dc.25330","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140656338","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A comparative study of INSM1 (clone MRQ70) immunoreactivity on CytoLyt® pretreated cytology and resection specimens of pancreatic neuroendocrine tumors 胰腺神经内分泌肿瘤细胞学预处理标本和切除标本上 INSM1(克隆 MRQ70)免疫反应的比较研究。
IF 1.3 4区 医学 Q3 Medicine Pub Date : 2024-04-24 DOI: 10.1002/dc.25328
Tiffany Jakowczuk BAS, Shuyue Ren MD, PhD

Introduction

Insulinoma-associated protein 1 (INSM1) is a newly characterized sensitive and specific immunohistochemical marker for neuroendocrine (NE) tumors. Whereas more traditional NE markers, such as chromogranin A and synaptophysin, are cytoplasmic, INSM1 is uniquely nuclear and thus could serve as a useful addition to NE tumor workup. While application of immunohistochemical studies to cytology specimens is becoming increasingly relevant, knowledge of the effects of the certain fixatives as well as the pattern and intensity of immunoexpression are important considerations.

Methods

Sixteen cases of pancreatic neuroendocrine tumor (PanNET) diagnosed between 2015 and 2021 underwent both fine-needle aspiration, which was subsequently prepared in CytoLyt®-fixed cytology cell block (CCB), and surgical resection, in which specimens were prepared into formalin-fixed paraffin embedded blocks (FFPE). For all samples, INSM1 immunoreactivity was classified according to staining intensity and extent, then compared between CCBs and matched FFPEs.

Results

All 16 FFPE specimens demonstrated strong and diffuse INSM1 immunoreactivity, while only 10/16 (62.5%) CCBs were positive. Of those 10, only 2/10 (20%) demonstrated strong and diffuse reactivity.

Conclusion

The choice of fixative has a demonstrable effect on the immunoreactivity of INSM1 in PanNET. Even though the sensitivity is lower in CytoLyt®-fixed cell block specimens, the addition of INSM1 is useful, especially in challenging cases that may be negative for one or more of the traditional NE markers.

简介胰岛素瘤相关蛋白 1(INSM1)是神经内分泌(NE)肿瘤新近发现的一种敏感而特异的免疫组化标记物。传统的 NE 标志物(如嗜铬粒蛋白 A 和突触素)具有细胞质特性,而 INSM1 则具有独特的细胞核特性,因此可作为 NE 肿瘤检查的有效补充。虽然免疫组化研究在细胞学标本中的应用正变得越来越重要,但了解某些固定剂的作用以及免疫表达的模式和强度也是重要的考虑因素。方法16例在2015年至2021年间确诊的胰腺神经内分泌肿瘤(PanNET)患者同时接受了细针穿刺抽吸术(随后制备成CytoLyt®固定的细胞学细胞块(CCB))和手术切除术(将标本制备成福尔马林固定的石蜡包埋块(FFPE))。结果所有 16 份 FFPE 标本都显示出强烈而弥漫的 INSM1 免疫反应,而只有 10/16 份(62.5%)CCB 标本呈阳性。结论固定液的选择对 PanNET 中 INSM1 的免疫反应有明显的影响。尽管 CytoLyt® 固定细胞块标本的灵敏度较低,但 INSM1 的添加还是很有用的,尤其是在一种或多种传统 NE 标记物阴性的高难度病例中。
{"title":"A comparative study of INSM1 (clone MRQ70) immunoreactivity on CytoLyt® pretreated cytology and resection specimens of pancreatic neuroendocrine tumors","authors":"Tiffany Jakowczuk BAS,&nbsp;Shuyue Ren MD, PhD","doi":"10.1002/dc.25328","DOIUrl":"10.1002/dc.25328","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Introduction</h3>\u0000 \u0000 <p>Insulinoma-associated protein 1 (INSM1) is a newly characterized sensitive and specific immunohistochemical marker for neuroendocrine (NE) tumors. Whereas more traditional NE markers, such as chromogranin A and synaptophysin, are cytoplasmic, INSM1 is uniquely nuclear and thus could serve as a useful addition to NE tumor workup. While application of immunohistochemical studies to cytology specimens is becoming increasingly relevant, knowledge of the effects of the certain fixatives as well as the pattern and intensity of immunoexpression are important considerations.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>Sixteen cases of pancreatic neuroendocrine tumor (PanNET) diagnosed between 2015 and 2021 underwent both fine-needle aspiration, which was subsequently prepared in CytoLyt®-fixed cytology cell block (CCB), and surgical resection, in which specimens were prepared into formalin-fixed paraffin embedded blocks (FFPE). For all samples, INSM1 immunoreactivity was classified according to staining intensity and extent, then compared between CCBs and matched FFPEs.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>All 16 FFPE specimens demonstrated strong and diffuse INSM1 immunoreactivity, while only 10/16 (62.5%) CCBs were positive. Of those 10, only 2/10 (20%) demonstrated strong and diffuse reactivity.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>The choice of fixative has a demonstrable effect on the immunoreactivity of INSM1 in PanNET. Even though the sensitivity is lower in CytoLyt®-fixed cell block specimens, the addition of INSM1 is useful, especially in challenging cases that may be negative for one or more of the traditional NE markers.</p>\u0000 </section>\u0000 </div>","PeriodicalId":11349,"journal":{"name":"Diagnostic Cytopathology","volume":null,"pages":null},"PeriodicalIF":1.3,"publicationDate":"2024-04-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/dc.25328","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140663196","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exploring cytologic features and potential diagnostic challenges of metastatic NUT carcinoma to the parotid gland: A case report and a comprehensive literature review 探索腮腺转移性 NUT 癌的细胞学特征和潜在诊断难题:病例报告和综合文献综述。
IF 1 4区 医学 Q4 MEDICAL LABORATORY TECHNOLOGY Pub Date : 2024-04-24 DOI: 10.1002/dc.25335
Crystal Y. Li BA, Salih Salihoglu MSc, Francisco J. Civantos MD, Jaylou M. Velez Torres MD

NUT carcinoma (NC) is a highly aggressive, poorly differentiated carcinoma that harbors a t(15:19) translocation, leading to the fusion of the NUTM1 gene. While the upper aerodigestive tract along the midline (head, neck, thorax, and mediastinum) is commonly reported as the primary site of NC, subsequent cases have emerged in diverse locations. Achieving a definitive diagnosis based solely on morphology is challenging; however, it can be achieved using immunohistochemistry (IHC) specific to the NUT antibody or by demonstrating the characteristic BRD4::NUTM1 fusion. Accurate and timely diagnosis can potentially inform patient management and guide treatment. While histologic documentation of NC is commonly found, there is a limited description of its cytologic features. A 39-year-old male with a history of sinonasal squamous cell carcinoma (SCC) presented with a right parotid mass aspirated via fine needle aspiration cytology (FNA). Histologic examination of the previous sinonasal pathology reviewed at our institution revealed sheets of primitive-appearing, monotonous, undifferentiated cells with distinct, prominent nucleoli. Additionally, there were foci of abrupt keratinization, accompanied by a notable neutrophilic infiltrate. The initial diagnosis of SCC was reclassified to NC and confirmed through NUT IHC and molecular testing. Although the parotid FNA initially suggested the possibility of a variety of small round blue cell tumors, it exhibited morphological similarities to the sinonasal tumor, leading to the diagnosis of metastatic NC. Cytomorphologic features of NC are limited and can overlap with various small round blue cell tumors. Correct classification is especially pivotal in the era of targeted therapy, considering the ongoing development and evaluation of BET inhibitors targeting BRD4.

NUT癌(NC)是一种侵袭性很强、分化程度很低的癌症,携带t(15:19)易位,导致NUTM1基因融合。虽然沿中线的上消化道(头颈部、胸部和纵隔)通常被报道为NC的原发部位,但随后在不同部位也出现了病例。仅根据形态学做出明确诊断是具有挑战性的;不过,可以使用针对 NUT 抗体的特异性免疫组化(IHC)或通过显示特征性的 BRD4::NUTM1 融合来做出诊断。准确、及时的诊断可为患者管理提供信息并指导治疗。虽然 NC 的组织学记录很常见,但对其细胞学特征的描述却很有限。一名 39 岁的男性患者曾患鼻窦鳞状细胞癌(SCC),经细针抽吸细胞学检查(FNA)发现右侧腮腺肿块。在本院进行的鼻窦病理组织学检查发现,患者鼻窦内有成片的原始、单调、未分化的细胞,细胞核明显突出。此外,还有一些突然角化的病灶,并伴有明显的中性粒细胞浸润。最初的 SCC 诊断被重新归类为 NC,并通过 NUT IHC 和分子检测得到证实。虽然腮腺 FNA 最初提示可能是各种小圆形蓝细胞瘤,但它表现出与鼻窦肿瘤相似的形态学特征,因此被诊断为转移性 NC。NC的细胞形态学特征有限,可与各种小圆形蓝细胞瘤重叠。考虑到目前正在开发和评估以BRD4为靶点的BET抑制剂,正确的分类在靶向治疗时代尤为重要。
{"title":"Exploring cytologic features and potential diagnostic challenges of metastatic NUT carcinoma to the parotid gland: A case report and a comprehensive literature review","authors":"Crystal Y. Li BA,&nbsp;Salih Salihoglu MSc,&nbsp;Francisco J. Civantos MD,&nbsp;Jaylou M. Velez Torres MD","doi":"10.1002/dc.25335","DOIUrl":"10.1002/dc.25335","url":null,"abstract":"<p>NUT carcinoma (NC) is a highly aggressive, poorly differentiated carcinoma that harbors a t(15:19) translocation, leading to the fusion of the <i>NUTM1</i> gene. While the upper aerodigestive tract along the midline (head, neck, thorax, and mediastinum) is commonly reported as the primary site of NC, subsequent cases have emerged in diverse locations. Achieving a definitive diagnosis based solely on morphology is challenging; however, it can be achieved using immunohistochemistry (IHC) specific to the NUT antibody or by demonstrating the characteristic <i>BRD4::NUTM1</i> fusion. Accurate and timely diagnosis can potentially inform patient management and guide treatment. While histologic documentation of NC is commonly found, there is a limited description of its cytologic features. A 39-year-old male with a history of sinonasal squamous cell carcinoma (SCC) presented with a right parotid mass aspirated via fine needle aspiration cytology (FNA). Histologic examination of the previous sinonasal pathology reviewed at our institution revealed sheets of primitive-appearing, monotonous, undifferentiated cells with distinct, prominent nucleoli. Additionally, there were foci of abrupt keratinization, accompanied by a notable neutrophilic infiltrate. The initial diagnosis of SCC was reclassified to NC and confirmed through NUT IHC and molecular testing. Although the parotid FNA initially suggested the possibility of a variety of small round blue cell tumors, it exhibited morphological similarities to the sinonasal tumor, leading to the diagnosis of metastatic NC. Cytomorphologic features of NC are limited and can overlap with various small round blue cell tumors. Correct classification is especially pivotal in the era of targeted therapy, considering the ongoing development and evaluation of BET inhibitors targeting BRD4.</p>","PeriodicalId":11349,"journal":{"name":"Diagnostic Cytopathology","volume":null,"pages":null},"PeriodicalIF":1.0,"publicationDate":"2024-04-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/dc.25335","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140664934","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Diagnostic Cytopathology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1